NSE - Free Realtime Quote
INR
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)
217.50
+0.11
(+0.05%)
As of 12:05:32 PM GMT+5:30. Market Open.
Loading chart for JAGSNPHARM.NS
- Previous Close
217.39 - Open
217.59 - Bid 217.52 x --
- Ask 217.77 x --
- Day's Range
216.03 - 219.08 - 52 Week Range
155.00 - 264.50 - Volume
8,085 - Avg. Volume
249,856 - Market Cap (intraday)
14.368B - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
33.26 - EPS (TTM)
6.54 - Earnings Date --
- Forward Dividend & Yield 2.50 (1.15%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
JAGSNPHARM.NS
14.81%
S&P BSE SENSEX (^BSESN)
4.99%
1-Year Return
JAGSNPHARM.NS
2.36%
S&P BSE SENSEX (^BSESN)
2.70%
3-Year Return
JAGSNPHARM.NS
43.74%
S&P BSE SENSEX (^BSESN)
24.89%
5-Year Return
JAGSNPHARM.NS
242.21%
S&P BSE SENSEX (^BSESN)
33.98%
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
14.31%
-
Return on Assets (ttm)
10.64%
-
Return on Equity (ttm)
18.18%
-
Revenue (ttm)
3.16B
-
Net Income Avi to Common (ttm)
451.9M
-
Diluted EPS (ttm)
6.54
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.15B
-
Total Debt/Equity (mrq)
3.77%
-
Levered Free Cash Flow (ttm)
366.1M
